Kanagawa, Japan

Sigeru Mitsuhashi


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Sigeru Mitsuhashi in Pharmaceutical Chemistry

Introduction

Sigeru Mitsuhashi is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that have the potential to impact drug design and therapeutic applications.

Latest Patents

Mitsuhashi holds a patent for N-substituted-7-amino-5-hydroxy-3-oxoheptanoic acid derivatives. The patent describes compounds represented by a specific structural formula, where various groups and metal atoms are defined to create intermediates for HMG-CoA reductase inhibitors. This important patent emphasizes the safe and easy preparation of these compounds, which play a crucial role in the development of drugs targeting cholesterol levels.

Career Highlights

Currently, Sigeru Mitsuhashi is associated with Takasago International Corporation, where he contributes his expertise in the development of pharmaceutical products. His focus on innovative chemical compounds showcases his commitment to advancing healthcare through scientific research and practical applications.

Collaborations

Throughout his career, Mitsuhashi has collaborated with talented colleagues, notably Tsukasa Sotoguchi and Yoshifumi Yuasa. These collaborations highlight the importance of teamwork in the progression of innovative research and the development of effective pharmaceutical solutions.

Conclusion

In summary, Sigeru Mitsuhashi has made a significant mark in the field of pharmaceutical innovations through his contributions and patent acquisition. His work not only aids in advancing drug development but also exemplifies the vital role of inventors in enhancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…